CTLA4 and myeloid sarcoma: They found a significant independent relative risk for MS susceptibility in noncarriers of IL-1ra allele 2 and CTLA-4 + 49 AA genotype as well as their combined effect, thus suggesting the involvement of IL-1ra VNTR and CTLA-4 A/G + 49 gene polymorphisms in the susceptibility to MS [123].